275 related articles for article (PubMed ID: 31581948)
1. Targeted delivery of antibiotics to the infected pulmonary tissues using ROS-responsive nanoparticles.
Wang Y; Yuan Q; Feng W; Pu W; Ding J; Zhang H; Li X; Yang B; Dai Q; Cheng L; Wang J; Sun F; Zhang D
J Nanobiotechnology; 2019 Oct; 17(1):103. PubMed ID: 31581948
[TBL] [Abstract][Full Text] [Related]
2. Folic acid-modified ROS-responsive nanoparticles encapsulating luteolin for targeted breast cancer treatment.
Wang Y; Wang Q; Feng W; Yuan Q; Qi X; Chen S; Yao P; Dai Q; Xia P; Zhang D; Sun F
Drug Deliv; 2021 Dec; 28(1):1695-1708. PubMed ID: 34402706
[TBL] [Abstract][Full Text] [Related]
3. Roxithromycin and rhEGF Co-loaded Reactive Oxygen Species Responsive Nanoparticles for Accelerating Wound Healing.
Ding J; Chen D; Hu J; Zhang D; Gou Y; Wu Y
Curr Drug Deliv; 2024; 21(5):753-762. PubMed ID: 37183469
[TBL] [Abstract][Full Text] [Related]
4. Reactive oxygen species-responsive dexamethasone-loaded nanoparticles for targeted treatment of rheumatoid arthritis via suppressing the iRhom2/TNF-α/BAFF signaling pathway.
Ni R; Song G; Fu X; Song R; Li L; Pu W; Gao J; Hu J; Liu Q; He F; Zhang D; Huang G
Biomaterials; 2020 Feb; 232():119730. PubMed ID: 31918224
[TBL] [Abstract][Full Text] [Related]
5. Antibiotic-loaded reactive oxygen species-responsive nanomedicine for effective management of chronic bacterial prostatitis.
Zheng J; Hu R; Yang Y; Wang Y; Wang Q; Xu S; Yao P; Liu Z; Zhou J; Yang J; Bao Y; Zhang D; Shen W; Zhou Z
Acta Biomater; 2022 Apr; 143():471-486. PubMed ID: 35259516
[TBL] [Abstract][Full Text] [Related]
6. Non-proinflammatory and responsive nanoplatforms for targeted treatment of atherosclerosis.
Dou Y; Chen Y; Zhang X; Xu X; Chen Y; Guo J; Zhang D; Wang R; Li X; Zhang J
Biomaterials; 2017 Oct; 143():93-108. PubMed ID: 28778000
[TBL] [Abstract][Full Text] [Related]
7. Antimicrobial efficacy of tobramycin polymeric nanoparticles for Pseudomonas aeruginosa infections in cystic fibrosis: formulation, characterisation and functionalisation with dornase alfa (DNase).
Deacon J; Abdelghany SM; Quinn DJ; Schmid D; Megaw J; Donnelly RF; Jones DS; Kissenpfennig A; Elborn JS; Gilmore BF; Taggart CC; Scott CJ
J Control Release; 2015 Jan; 198():55-61. PubMed ID: 25481442
[TBL] [Abstract][Full Text] [Related]
8. Bacteria-Targeting Nanoparticles with ROS-Responsive Antibiotic Release to Eradicate Biofilms and Drug-Resistant Bacteria in Endophthalmitis.
Yu J; Xu H; Wei J; Niu L; Zhu H; Jiang C
Int J Nanomedicine; 2024; 19():2939-2956. PubMed ID: 38529364
[TBL] [Abstract][Full Text] [Related]
9. Antibiotic-free nanotherapeutics: ultra-small, mucus-penetrating solid lipid nanoparticles enhance the pulmonary delivery and anti-virulence efficacy of novel quorum sensing inhibitors.
Nafee N; Husari A; Maurer CK; Lu C; de Rossi C; Steinbach A; Hartmann RW; Lehr CM; Schneider M
J Control Release; 2014 Oct; 192():131-40. PubMed ID: 24997276
[TBL] [Abstract][Full Text] [Related]
10. Tailored Nanocarriers for the Pulmonary Delivery of Levofloxacin against Pseudomonas aeruginosa: A Comparative Study.
Derbali RM; Aoun V; Moussa G; Frei G; Tehrani SF; Del'Orto JC; Hildgen P; Roullin VG; Chain JL
Mol Pharm; 2019 May; 16(5):1906-1916. PubMed ID: 30900903
[TBL] [Abstract][Full Text] [Related]
11. Targeted Therapy of Atherosclerosis by a Broad-Spectrum Reactive Oxygen Species Scavenging Nanoparticle with Intrinsic Anti-inflammatory Activity.
Wang Y; Li L; Zhao W; Dou Y; An H; Tao H; Xu X; Jia Y; Lu S; Zhang J; Hu H
ACS Nano; 2018 Sep; 12(9):8943-8960. PubMed ID: 30114351
[TBL] [Abstract][Full Text] [Related]
12. Docetaxel-loaded pH/ROS dual-responsive nanoparticles with self-supplied ROS for inhibiting metastasis and enhancing immunotherapy of breast cancer.
Wang Y; Wang Q; Wang X; Yao P; Dai Q; Qi X; Yang M; Zhang X; Huang R; Yang J; Wang Q; Xia P; Zhang D; Sun F
J Nanobiotechnology; 2023 Aug; 21(1):286. PubMed ID: 37608285
[TBL] [Abstract][Full Text] [Related]
13. Moxifloxacin releasing intraocular implant based on a cross-linked hyaluronic acid membrane.
Kim DJ; Jung MY; Park JH; Pak HJ; Kim M; Chuck RS; Park CY
Sci Rep; 2021 Dec; 11(1):24115. PubMed ID: 34916593
[TBL] [Abstract][Full Text] [Related]
14. A pH/ROS dual-responsive and targeting nanotherapy for vascular inflammatory diseases.
Zhang R; Liu R; Liu C; Pan L; Qi Y; Cheng J; Guo J; Jia Y; Ding J; Zhang J; Hu H
Biomaterials; 2020 Feb; 230():119605. PubMed ID: 31740099
[TBL] [Abstract][Full Text] [Related]
15. Bioinspired Heteromultivalent Ligand-Decorated Nanotherapeutic for Enhanced Photothermal and Photodynamic Therapy of Antibiotic-Resistant Bacterial Pneumonia.
Zhao Y; Yu C; Yu Y; Wei X; Duan X; Dai X; Zhang X
ACS Appl Mater Interfaces; 2019 Oct; 11(43):39648-39661. PubMed ID: 31591880
[No Abstract] [Full Text] [Related]
16. Antimicrobial Peptide-Loaded Nanoparticles as Inhalation Therapy for
Falciani C; Zevolini F; Brunetti J; Riolo G; Gracia R; Marradi M; Loinaz I; Ziemann C; Cossío U; Llop J; Bracci L; Pini A
Int J Nanomedicine; 2020; 15():1117-1128. PubMed ID: 32110011
[TBL] [Abstract][Full Text] [Related]
17. A New Era of Pulmonary Delivery of Nano-antimicrobial Therapeutics to Treat Chronic Pulmonary Infections.
Merchant Z; Buckton G; Taylor KM; Stapleton P; Saleem IY; Zariwala MG; Somavarapu S
Curr Pharm Des; 2016; 22(17):2577-98. PubMed ID: 26983671
[TBL] [Abstract][Full Text] [Related]
18. ROS-responsive nano-drug delivery system combining mitochondria-targeting ceria nanoparticles with atorvastatin for acute kidney injury.
Yu H; Jin F; Liu D; Shu G; Wang X; Qi J; Sun M; Yang P; Jiang S; Ying X; Du Y
Theranostics; 2020; 10(5):2342-2357. PubMed ID: 32104507
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of colistin combination therapy in a mouse model of pneumonia caused by multidrug-resistant Pseudomonas aeruginosa.
Aoki N; Tateda K; Kikuchi Y; Kimura S; Miyazaki C; Ishii Y; Tanabe Y; Gejyo F; Yamaguchi K
J Antimicrob Chemother; 2009 Mar; 63(3):534-42. PubMed ID: 19147523
[TBL] [Abstract][Full Text] [Related]
20. Nanoparticle Formulation of Moxifloxacin and Intramuscular Route of Delivery Improve Antibiotic Pharmacokinetics and Treatment of Pneumonic Tularemia in a Mouse Model.
Clemens DL; Lee BY; Plamthottam S; Tullius MV; Wang R; Yu CJ; Li Z; Dillon BJ; Zink JI; Horwitz MA
ACS Infect Dis; 2019 Feb; 5(2):281-291. PubMed ID: 30480992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
